UBS AM
IRON icon

UBS AM’s Disc Medicine IRON Stock Holding History

UBS AM’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.09M Sell
110,890
-3,461
-3% -$240K ﹤0.01% 1393
2025
Q4 		$9.08M Buy
114,351
+22,971
+25% +$1.94M ﹤0.01% 1164
2025
Q3 		$6.04M Sell
91,380
-30,204
-25% -$1.8M ﹤0.01% 1285
2025
Q2 		$6.44M Buy
121,584
+25,027
+26% +$1.18M ﹤0.01% 1581
2025
Q1 		$4.79M Buy
96,557
+3,454
+4% +$192K ﹤0.01% 1600
2024
Q4 		$5.9M Buy
93,103
+74,454
+399% +$4.31M ﹤0.01% 1523
2024
Q3 		$916K Buy
18,649
+3,312
+22% +$155K ﹤0.01% 2437
2024
Q2 		$691K Buy
15,337
+10,487
+216% +$356K ﹤0.01% 2536
2024
Q1 		$302K Buy
+4,850
New +$314K ﹤0.01% 2395

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return